This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an investor presentation, Insmed stated the drug could generate $5bn in peak sales. The future for Brinsupri is looking bright in its untreaded indication. GlobalData reckons Insemed has a blockbuster on its hands, forecasting sales of $1.7bn by 2033. Around 500,000 people in the US are estimated to have NCFB, according to Insmed.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
Students often enjoy engaging in multiple locations due to the appeal of having the same platform while observing how the community needs differ from pharmacy to pharmacy. We specialize in clinical services including medication synchronization, blister packaging, and medication therapy management (MTM).
By GlobalData Learn more about Strategic Intelligence AxSpA is a chronic inflammatory disease that typically presents when patients are in their 30s, impacting the spine and sacroiliac joints and causing significant pain, stiffness and reduced mobility. Don’t let policy changes catch you off guard.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
More than 30,000 patients have been treated with CAR T cell therapies, with studies including an analysis of BMS presented recently showing that most serious adverse events occur within the first two weeks of infusion. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
Frankie Fattorini July 31, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Lean mass loss and weight regain associated with blockbuster drugs like Ozempic and Mounjaro present opportunity for mitochondria-targeting alternatives. Give your business an edge with our leading industry insights.
Data, Value Dossiers, and the Role of HEOR One of the most powerful tools in pharmaceutical market access is the AMCP dossier a comprehensive value package delivered to payers. Tools and Partnerships That Enhance Access Market access success isnt just about what you presentits how you communicate it.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
But even if a facility is already present, and it’s only about expanding or shifting production to a different drug, everything has to be FDA-approved. And, so I think any decision would depend on how much certainty they have with respect to what the market will look like, at least in the next 5–10 years.
With no approved treatments available, present management strategies focus on symptomatic treatments and lifestyle modifications, which fall short of addressing the disease’s profound and persistent effects. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
Nevertheless, both present logistical challenges when operating across different regulatory environments. How will RFK Jr’s American dream for vaccines play out? Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Sign up for our daily news round-up!
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
Manasi Vaidya July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The Maryland Prescription Drug Affordability Board (PDAB) found that Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin) present affordability challenges for the residents of Maryland.
By GlobalData Learn more about Strategic Intelligence Starmer emphasised that the NHS must seize the “enormous opportunities” presented by developments in science and technology. How will RFK Jr’s American dream for vaccines play out? Stay proactive with real-time data and expert analysis.
Find out more Office of Management and Budget Director Russell Vought told reporters that the White House is on board with the substitute amendment to the rescissions package. How will RFK Jr’s American dream for vaccines play out? Data Insights The gold standard of business intelligence.
The FDA has recognised that the neurodevelopmental outcome data presented so far are robust. In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead.
It is no longer about brands or packaging – nor cannabis in the traditional sense. Crucially, companies must present themselves as well-run businesses operating in the cannabis sector, not simply “cannabis companies.” Give your business an edge with our leading industry insights.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
While detailed results will be presented at an upcoming conference in September, analysts at William Blair said investors will likely be disappointed by the current readout. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Predictably, the news of Lilly taking up the option of a confidential reimbursement price for Mounjaro has prompted numerous sensationalist reports in German media, in which Lilly is presented as having used its influence to bring confidential pricing into effect. Give your business an edge with our leading industry insights.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
At the 2025 International AIDS Society (IAS) meeting, taking place from 13 to 17 July in Kigali, Rwanda, researchers will present several studies that address the current political and financial issues affecting the HIV response, including the implications for Africa and the rest of the world.
On clinical presentation, ocular MG patients show symptoms limited to eye muscles, and generalised MG patients show symptoms involving broader muscle groups. Data Insights The gold standard of business intelligence. The choice of treatment is dependent on a patient’s disease stage, progression and refractory status.
Recently, Enterome announced its plan to present new data at the International Conference on Malignant Lymphoma (ICML) in Lugano on 21 June 2025. The data will demonstrate the impact of EO2463 in conjunction with standard care for relapsed and refractory iNHL subjects. Give your business an edge with our leading industry insights.
A clue to its outlook will likely present itself in the next ACIP meeting, though the long-term future of vaccines in the US with RFK Jr at the HHS helm remains unclear. They will likely be the first target.” As with most changes under the Trump administration, sentiment in the vaccine landscape is swiftly oscillating.
In terms of geography, our analysis indicates that there is significant R&D development of CAR T-cells in China and approval of these agents in other markets would present a potentially significant challenge to established therapies in the broader cell therapy space.” How will RFK Jr’s American dream for vaccines play out?
At the 2025 Congress of the European Hematology Association (EHA 2025), held from 12 June 12 to 15 June in Milan, Italy, preliminary dose-escalation and optimisation results from the global, multicentre, open-label, single-arm Phase I/II SYRUS clinical trial (NCT06137118) were presented on the second day.
In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.
Large datasets of well curated data, presented in the same format, are particularly amenable to profiling by AI systems. AI-based optic systems, for example, can enhance defect screening in manufacturing by scanning for packaging defects. Nature Communications. cited 2025Feb]. Available from: [link] 15. 2020; 11(1): 233.
MSSG stresses the importance of transparency in relation to shortages and highlights the need for all stakeholders to communicate in an objective and responsible way to avoid any undue public concern. In addition, MSSG supports temporary national measures such as unit dose dispensing and compounding.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. Develop Clear and Balanced Messaging Effective communication is at the heart of pharmaceutical marketing. Keep thorough records of approvals for future reference.
Future onsite-and-online conferences present significant decision-making challenges to the pharmaceutical industry, amply demonstrated by the sponsored symposia options, shown in Figure 5, which were available at the 2021 EAACI hybrid conference. Figure 5 Sponsored symposia options at the EAACI hybrid congress 2021.
Clearly, over the last few months, sales reps have had limited in-person access to HCPs, which has presented a challenge. “A Interactions between sales reps and HCPs has shifted to more digital forms of communication as a result of the lack of face-to-face interaction. Joanna Carlish. Personalising marketing content.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content